The Patent Finder

Laboratoires Goemar

Also on record
Records under this name other than the patents Laboratoires Goemar holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Laboratoires Goemar

PatentTitleStatus Expires Confidence
US 8,505,774Fluid delivery device
Formerly held
Lapsed on the fee record
Ended Aug 13, 2025 · From the USPTO record
Lapsed on the fee recordEnded Aug 13, 2025From the USPTO record
US 6,979,665Agent for stimulation of the natural defences of plants and methods for using it
Term ended
Term ended Mar 12, 2023 · From the USPTO record
Term endedTerm ended Mar 12, 2023From the USPTO record
US 6,451,352Use of iso-osmotic saline solutions, method for preparing same and medicine based on said solutions
Formerly held
Term ended
Term ended May 24, 2021 · From the USPTO record
Term endedTerm ended May 24, 2021From the USPTO record
US 6,511,838Genes coding for &bgr;-agarases and their use for producing agar biodegradation enzymes
Term ended
Term ended Dec 12, 2020 · From the USPTO record
Term endedTerm ended Dec 12, 2020From the USPTO record
US 6,387,847Method for stimulating natural control system of plants
Term ended
Term ended Jan 18, 2020 · From the USPTO record
Term endedTerm ended Jan 18, 2020From the USPTO record
US 6,984,630Endofucanases and method using same for preparing fuco-oligosaccharides from fucanes, bacterium producing endofucanases and uses of fuco-oligosaccharides for plant protection
Term ended
Term ended Sep 21, 2019 · From the USPTO record
Term endedTerm ended Sep 21, 2019From the USPTO record
US 6,921,540Hypoosmotic saline solutions, method for preparing same and medicines based on said solution
Formerly held
Term ended
Term ended Jul 5, 2019 · From the USPTO record
Term endedTerm ended Jul 5, 2019From the USPTO record
US 6,333,185Glycosyl hydrolase genes and their use for producing enzymes for the biodegradation of carrageenans
Term ended
Term ended Apr 5, 2019 · From the USPTO record
Term endedTerm ended Apr 5, 2019From the USPTO record
US 7,070,778Therapeutical combination against cancer
Lapsed on the fee record
Ended Jul 4, 2018 · From the USPTO record
Lapsed on the fee recordEnded Jul 4, 2018From the USPTO record
US 7,008,931Anti-inflammatory and healing medicine based on laminarin sulphate
Lapsed on the fee record
Ended Mar 7, 2018 · From the USPTO record
Lapsed on the fee recordEnded Mar 7, 2018From the USPTO record
10 of 30 patents shown.
Pro members see all 30.
Pro members: see all 30 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited